from Reuters: Health News https://ift.tt/3cVIC9n
Wednesday, 29 April 2020
BerGenBio shares more than double on COVID-19 drug trial news
Shares of Norwegian pharmaceutical company BerGenBio rose nearly 160% on Wednesday after news that a drug it is developing has been selected for a British trial of potential COVID-19 treatments.
from Reuters: Health News https://ift.tt/3cVIC9n
from Reuters: Health News https://ift.tt/3cVIC9n
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment